Nanjing Chia-tai Tianqing Pharmaceutical

Works in Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Women's health

Nanjing Chia-tai Tianqing Pharmaceutical is a clinical trial sponsor. It has 11 active clinical trials with 1,128 planned participants, across 13 therapeutic areas. Since 2021 it has completed 3 trials and stopped 0 early.

Trial track record · since 2021

11Active trials1,128 planned participants
3Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 11 active trials

StageTrialStatus

Questions about Nanjing Chia-tai Tianqing Pharmaceutical

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-03.

Approve Suite is not affiliated with Nanjing Chia-tai Tianqing Pharmaceutical.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.